BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35530288)

  • 1. β-elemene suppresses tumor metabolism and stem cell-like properties of non-small cell lung cancer cells by regulating PI3K/AKT/mTOR signaling.
    Cheng G; Li L; Li Q; Lian S; Chu H; Ding Y; Li C; Leng Y
    Am J Cancer Res; 2022; 12(4):1535-1555. PubMed ID: 35530288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways.
    Zhan YH; Liu J; Qu XJ; Hou KZ; Wang KF; Liu YP; Wu B
    Asian Pac J Cancer Prev; 2012; 13(6):2739-44. PubMed ID: 22938451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells.
    Liu J; Hu XJ; Jin B; Qu XJ; Hou KZ; Liu YP
    J Pharm Pharmacol; 2012 Jan; 64(1):146-53. PubMed ID: 22150682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs.
    Li QQ; Wang G; Huang F; Li JM; Cuff CF; Reed E
    Med Oncol; 2013 Mar; 30(1):488. PubMed ID: 23397083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis.
    Li QQ; Wang G; Zhang M; Cuff CF; Huang L; Reed E
    Oncol Rep; 2009 Jul; 22(1):161-70. PubMed ID: 19513519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis.
    Li L; Zhao D; Cheng G; Li Q; Chu Y; Chu H; Ding Y; Li C
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32463461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
    Li J; JunYu ; Liu A; Wang Y
    Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT.
    Liang Y; Li S; Zheng G; Zhang L
    Acta Histochem; 2020 May; 122(4):151538. PubMed ID: 32183989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells
    Yang H; Li H; Lu S; Shan S; Guo Y
    Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
    Li QQ; Wang G; Reed E; Huang L; Cuff CF
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):868-76. PubMed ID: 22545969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway.
    Liu Y; Jiang ZY; Zhou YL; Qiu HH; Wang G; Luo Y; Liu JB; Liu XW; Bu WQ; Song J; Cui L; Jia XB; Feng L
    Biomed Pharmacother; 2017 Sep; 93():490-497. PubMed ID: 28672279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells.
    Lee RX; Li QQ; Reed E
    Anticancer Res; 2012 Aug; 32(8):3103-13. PubMed ID: 22843880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
    Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
    Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
    BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis.
    Liang D; Yang M; Guo B; Yang L; Cao J; Zhang X
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1865-77. PubMed ID: 22736026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway.
    Yiyan S; Yang S; Li D; Li W
    Curr Cancer Drug Targets; 2022; 22(1):86-95. PubMed ID: 34325639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.